English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Purpose: To evaluate the validity of DIPSI, (Diabetes and Pregnancy Study Group India) a single step test, as a screening tool for GDM and to find out the incidence and onset of GDM with respect to period of gestation. Materials and Methods: One year prospective study was conducted on 300 antenatal women in all three trimesters with DIPSI – Single step test. DIPSI positive patients underwent diagnostic OGTT, by 75 gm glucose. Patients were diagnosed as GDM by WHO Criteria (1999). Results: DIPSI had sensitivity of 100%, specificity of 94.6%. Of the 300 patients subjected to the study, overall incidence of GDM was 25.3% and 0.7% were diagnosed with overt diabetes. During the first trimester 4% had GDM whereas 0.7% had overt diabetes. During the second and third trimester 12.5% and 15.3 % of patients were newly diagnosed with GDM respectively. Conclusion: This evidence not only validates DIPSI as simple and efficient screening test but also emphasizes the importance of subjecting all the pregnant women in all 3 trimesters to test for screening for GDM. And therefore this test should become part of the routine antenatal investigations.

The validity of single step test (DIPSI) for screening for GDM in all trimesters of pregnancy